GLUE Lecture | The Next Generation of Lateral Flow Assays: Integration of Nanomaterials - POCTRN

Center news

null GLUE Lecture | The Next Generation of Lateral Flow Assays: Integration of Nanomaterials

GLUE Lecture | The Next Generation of Lateral Flow Assays: Integration of Nanomaterials

About the Speaker

Arben Merkoçi, PhD is currently ICREA Professor and director of the Nanobioelectronics & Biosensors Group at Institut Català de Nanociencia i Nanotecnologia (ICN2), a BIST center situated at Autonomous University of Barcelona (UAB) campus. Prof. Merkoçi’s research is focused on the design and application of cutting-edge nanotechnology and nanoscience-based biosensors with interest for diagnostics. These nanobiosensors are based on the integration of biological molecules (DNA, antibodies, cells, and enzymes) and other (bio)receptors with micro- and nanostructures and applied in diagnostics, environmental monitoring or safety and security.
 

About the GLUE Lecture Series

The Oliver Brand Memorial Lecture Series includes Global Lectures Uniting Everyone (GLUE) which is the Atlanta Center for Microsystems Engineered Point-of-care Technologies (ACME POCT) flagship event series. These talks serve as our primary venue to educate on the entrepreneurial pathway and product lifecycle. It provides a forum to pitch clinical problems and teach about the technologies most promising for meeting these clinical needs.

When: 
Wednesday, January 10, 2024
10:30AM ET 

Register for the webinar >

RADx: Rapid Acceleration of Diagnostics

In response to the COVID-19 pandemic, the Rapid Acceleration of Diagnostics (RADx®) initiative was formed to accelerate the development, validation, and commercialization of innovative point-of-care and home-based tests, as well as improvements to clinical laboratory tests, that can directly detect SARS-CoV-2, the virus that causes COVID-19.

ABOUT RADx

In the News 

Two New Over-the-Counter At-Home COVID-19 Tests Brought to U.S. Market Quickly by Biden-Harris Administration

New HHS actions add to Biden administration efforts to increase access to easy-to-use over-the-counter COVID-19 tests

NIH RADx initiative expands COVID-19 testing innovation for additional types of rapid tests

The need for new test verification and regulatory support for innovative diagnostics

NIH-funded screening study builds case for frequent COVID-19 antigen testing

RADx partnerships speed new COVID testing

One Year of RADx Tech Success

Publication reveals essential ingredients of the groundbreaking NIH RADx national diagnostics effort 

Innovative COVID-19 Testing RADx Tech Reports Unveiled in Special Issue of IEEE Open Journal of Engineering in Medicine and Biology

Luminostics Announces FDA Authorization and Production Scale-Up of US-Manufactured Smartphone-Based COVID-19 Rapid Test

RADx Expects COVID-19 Portfolio to Accelerate an Era of At-Home Infectious Disease Testing (Login Required)

VIC Foundry, Inc. Receives NIH RADx Funding for Development of an At-home Molecular Diagnostic Test for COVID-19

Ceres Nanosciences Opens Advanced Particle Manufacturing Plant in Northern Virginia to Expand Nanotrap® Particle Manufacturing Capacity for COVID-19 Testing

COVID-19 Testing: Three Breakthrough Solutions in the RADx Initiative

NIH Director: Collaboration Amid Chaos, and Biden’s First 100 Days - How Francis Collins sees the COVID response changing with the new administration

The National Strategy From the COVID-19 Response and Pandemic Preparedness

Winners of HHS Design-a-thon to Develop Innovative Digital Health Tools for COVID-19 At-Anywhere Diagnostic Tests Announced

The Need for More and Better Testing for COVID-19